KÇKemal Çavdarlı

Kemal Çavdarlı

*This is an algorithmically generated author record based on publicly available information.

Kemal Çavdarlı has a total of 8 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Agomelatine restores apoptotic and glial homeostasis in methotrexate-induced cortical neurotoxicity

    by Zafer Usta, Kemal Çavdarlı, Özlem Türkoglu, Adem Milletsever, Sevilay Kılınçkaya


  • L‐Carnitine Attenuates Methotrexate‐Induced Nephrotoxicity by Modulating BAX/BCL2 Apoptotic Signaling and Preserving Podocyte, Endothelial, and Tubular Integrity

    by Özlem Türkoglu, Zafer Usta, Kemal Çavdarlı, Simge Garlı, Nur Alp

    Methotrexate (MTX), a common chemotherapeutic and immunosuppressive drug, is limited by dose‐dependent nephrotoxicity mediated by oxidative stress, mitochondrial dysfunction, and apoptosis. L‐carnitine (LCR), a mitochondrial cofactor with antioxidant and anti‐apoptotic properties, may counteract these mechanisms. This study aims to determine whether LCR mitigates MTX‐induced nephrotoxicity by rebalancing the BAX/BCL2 apoptotic axis and preserving renal compartment integrity (endothelial CD31, tubular cytokeratin, podocyte WT1). Twenty‐four female Wistar rats were randomized into Control, MTX (20 mg/kg, i.p., Day 5), LCR (200 mg/kg/day, i.p., 10 days), and MTX + LCR groups ( n = 6 each). Renal injury was assessed by serum creatinine, urea, BUN, histopathology, immunohistochemistry (CD31, cytokeratin, WT1), and RT‐qPCR for BAX/BCL2. MTX impaired renal function, caused vascular hyperemia, hemorrhage, and tubular necrosis, increased CD31, cytokeratin, and BAX and decreased WT1 and BCL2. LCR co‐treatment improved biochemical indices, reduced lesions, decreased CD31 and cytokeratin, partially restored WT1 and re‐balanced apoptosis (BAX↓, BCL2↑). LCR disrupts oxidative stress, the mitochondrial apoptosis cascade, and preserves endothelial, tubular, and podocyte integrity in MTX nephrotoxicity.


  • L‐Carnitine Attenuates Methotrexate‐Induced Cortical Neurotoxicity via Glial and Apoptotic Pathways

    by Kemal Çavdarlı, Zafer Usta, Özlem Türkoglu, Harun Karaca, Ümit Kara

    Methotrexate (MTX) is a widely used chemotherapeutic and immunosuppressive agent, but its clinical application is limited by dose‐dependent neurotoxicity, particularly in the cerebral cortex. MTX‐induced injury involves oxidative imbalance, mitochondrial dysfunction, glial activation, and apoptosis. L‐carnitine (LCR), a mitochondrial cofactor with antioxidant and antiapoptotic properties, has been proposed as a potential neuroprotective agent. This study investigated whether LCR could attenuate MTX‐induced cortical damage in rats. Twenty‐four female Wistar rats were randomly assigned to four groups ( n = 6): control, MTX, LCR, and MTX + LCR. MTX (20 mg/kg, i.p.) was given on Day 5, whereas LCR (200 mg/kg, i.p.) was administered daily for 10 days. Cortical tissue was evaluated histopathologically, immunohistochemically for GFAP and OLIG2, and by qRT‐PCR for BAX and BCL2 expression. MTX caused severe cortical degeneration, perivascular edema, reactive astrogliosis, oligodendroglial activation, and a significant increase in the BAX/BCL2 ratio. LCR co‐treatment markedly reduced histological injury, attenuated glial activation, and restored apoptotic balance toward cell survival. LCR alone showed no adverse effects compared with controls. These findings demonstrate that LCR provides effective neuroprotection against MTX‐induced cortical injury in rats.